Clinical trial
The SongDanceT1 Study: Stress, Ongoing Self- Monitoring and Diabetes, Nerve Stimulation and Cognitive Empowerment. An Implementation Study Combined With an Observer-blinded Randomized Controlled Interventional Trial (SongDance T1D)
NCT06087679 is registered in ClinicalTrials.gov with Steno Diabetes Center Copenhagen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The SongDanceT1 Study: Stress, Ongoing Self- Monitoring and Diabetes, Nerve Stimulation and Cognitive Empowerment. An Implementation Study Combined With an Observer-blinded Randomized Controlled Interventional Trial (SongDance T1D)
- Lead sponsor
- Steno Diabetes Center Copenhagen
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- July 8, 2022
- Completion date
- February 1, 2024
- Enrollment
- 120 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
autonomic dysfunction, stress, psychological